Cbeyond Fourth Quarter in Line With Estimates as Churn Remains Elevated
Cbeyond’s fourth quarter 2013 revenue and EBITDA were in line with the consensus expectations. With…
Author Mike Underwood
KaloBios Pharmaceuticals, Inc. Earnings Highlighted by Potential for Two Trial Readouts Before Year End
After the markets closed on Thursday, KaloBios reported fourth-quarter financial results and an update of…
Progressive Corp Adverse Development Drive Earnings Miss
Progressive February results were a little uneven given severe non-catastrophe winter weather and adverse development…